生体吸収性スキャフォールド：企業動向...市場調査レポートについてご紹介

1 Table of Contents
1.1 List of Tables
2 Introduction
2.1 Catalyst
2.2 Related Reports
3 Competitive Assessment
3.1 Overview
3.2 Absorb BVS – Abbott Vascular
3.2.1 Efficacy
3.3 Remedy – Kyoto Medical Planning
3.3.1 Efficacy
3.4 DESolve – Elixir Medical Corperation
3.4.1 Efficacy
3.5 Pure – Arterial Remodeling Technologies
3.5.1 Efficacy
4 Pipeline Products
4.1 Overview
4.2 Coronary Artery Disease – Pipeline Products
4.2.1 Overview
4.2.2 Polymer-Based Bioabsorbable Scaffolds
4.2.3 Metallic Bioabsorbable Scaffolds
4.2.4 Summary
4.3 Peripheral Artery Disease – Peripheral Bioabsorbable Scaffold Product Pipeline
4.3.1 Overview
4.3.2 Summary
5 Current and Future Players
5.1 Overview
5.2 Trends in Corporate Strategy
5.3 Company Profiles
5.3.1 Abbott Vascular
5.3.2 Kyoto Medical Planning Co., Ltd.
5.3.3 Arterial Remodeling Technologies
5.3.4 Elixir Medical Corporation
5.3.5 Cardionovum
5.3.6 Reva Medical
5.3.7 OrbusNeich Medical
5.3.8 Amaranth Medical
5.3.9 Biotronik
5.3.10 Lepu Medical Technology
5.3.11 HuaAn Biotechnology Co., Ltd.
5.3.12 Lifetech Scientific (Shenzhen) Co., LTD. (Lifetech Shenzhen)
5.3.13 Arterius
5.3.14 S3V Vascular Technologies
5.3.15 Tepha Inc.
5.3.16 Zorion Medical
5.3.17 Xenogenics Corporation
5.3.18 Meril Life Sciences
5.3.19 Boston Scientific Corporation
5.3.20 Icon Interventional Systems
6 Appendix
6.1 Bibliography
6.2 Abbreviations
6.3 Report Methodology
6.3.1 Overview
6.3.2 Coverage
6.3.3 Primary Research -Key Opinion Leader Interviews
6.3.4 Primary Research Interviews – Physician and Industry Participants
6.3.5 Physician Survey
6.3.6 Expert Panel Validation
6.3.7 Secondary Research
6.4 Forecasting Methodology
6.5 Physicians and Specialists Included in This Study
6.6 About the Authors
6.6.1 Analysts
6.6.2 James Coutcher, Global Head of Healthcare
6.7 About GlobalData
6.8 Contact Us
6.9 Disclaimer